SLC5A2 and diabetes mellitus: Given the prevailing challenges in clinical 18F-FDG-PET imaging for patients with diabetes, this study aimed to compare the effects of SGLT2 inhibitors and insulin, and to provide clues for diabetic patients to choose appropriate hypoglycemic drugs in 18F-FDG PET imaging diagnosis.